Kiora Pharmaceuticals's market cap is currently $10.53M. The company's EPS TTM is $-0.535; its P/E ratio is ―; Kiora Pharmaceuticals is scheduled to report earnings on February 28, 2025, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 12.06K	$ 2.69M
Gross Profit	$ -4.03M	$ -134.03K	$ -227.27K	$ -188.16K	$ 2.68M
Operating Income	$ -12.59M	$ -12.31M	$ -16.94M	$ -8.19M	$ -7.00M
EBITDA	$ -12.35M	$ -13.55M	$ -13.73M	$ -6.65M	$ -6.79M
Net Income	$ -12.51M	$ -13.58M	$ -16.39M	$ -8.09M	$ -7.10M
Balance Sheet
Cash & Short-Term Investments	$ 2.45M	$ 5.96M	$ 7.85M	$ 1.19M	$ 3.78M
Total Assets	$ 13.71M	$ 18.68M	$ 18.06M	$ 15.16M	$ 10.11M
Total Debt	$ 106.89K	$ 105.78K	$ 209.41K	$ 362.12K	$ 83.93K
Net Debt	$ -2.35M	$ -5.86M	$ -7.65M	$ -823.56K	$ -3.69M
Total Liabilities	$ 7.60M	$ 7.27M	$ 8.83M	$ 8.16M	$ 3.49M
Stockholders' Equity	$ 6.11M	$ 11.41M	$ 9.22M	$ 7.00M	$ 6.62M
Cash Flow
Free Cash Flow	$ -9.56M	$ -10.43M	$ -10.95M	$ -7.45M	$ -8.15M
Operating Cash Flow	$ -9.56M	$ -10.43M	$ -10.89M	$ -7.32M	$ -8.15M
Investing Cash Flow	$ 0.00	$ 6.38K	$ -157.02K	$ -244.44K	$ 0.00
Financing Cash Flow	$ 5.97M	$ 8.62M	$ 17.80M	$ 5.00M	$ 3.92M

Currency in USD

Kiora Pharmaceuticals Earnings and Revenue History

Income Statement >

Kiora Pharmaceuticals Debt to Assets

Balance Sheet >

Kiora Pharmaceuticals Cash Flow

Cash Flow >

Kiora Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing